Skip to content

Fat-induced Release of GLP-1 in Humans

Short Fatty Acids-induced Release of GLP-1 in Humans

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02264951
Enrollment
12
Registered
2014-10-15
Start date
2013-10-31
Completion date
2014-02-28
Last updated
2014-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Keywords

Short fatty acids, 2-oleoyl glycerol, GLP-1 secretion, C8-diet oil, GIP secretion

Brief summary

This study compared the incretin-releasing effect of C8-diet oil and tributyrin with that of 20 ml olive oil on a molar basis in human volunteers.

Detailed description

A structured triglyceride (1,3-di-octanoyl-2-oleoyl-glycerol, called C8-diet oil), which upon digestion results in generation of two medium-chain fatty acids and 2-oleoyl-glycerol (2-OG), may lead to activation of GPR119 only, since medium fatty acids are poor agonists for fatty acid receptors.

Interventions

DIETARY_SUPPLEMENTTributyrin

a triglyceride containing three C4-acids

DIETARY_SUPPLEMENTC8-diet oil

a triglyceride containing 2 C8-fatty acids and one oleic acid at sn-2 position

DIETARY_SUPPLEMENTOlive oil

a triglyceride containing mostly three oleic acids

DIETARY_SUPPLEMENTCarrot

mainly water and glucose

Sponsors

University of Copenhagen
CollaboratorOTHER
Glostrup University Hospital, Copenhagen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Caucasian healthy male subjects * Body mass index (BMI) 19 to 25 kg/m2 * Informed consent

Exclusion criteria

* Anaemia * Diabetes mellitus * Gastrointestinal diseases or operations interacting with intestinal absorption

Design outcomes

Primary

MeasureTime frame
plasma GLP-12 hours postprandial
plasma GIP2 hours postprandial

Secondary

MeasureTime frame
plasma glucose2 hours postprandial
plasma insulin2 hours postprandial
plasma CCK2 hour postprandial
plasma neurotensin2 hour postprandial
plasma PYY2 hours postprandial

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 17, 2026